Interrogation of the Chandran prostate cancer dataset (60 localized tumors and 63 adjacent, normal prostate) (Chandran et al., 2005) suggests that CHRDL1 is downregulated by prostate tumors in general. This evidence concerns the gene CHRDL1 and prostate neoplasm.